If you made any changes in Pure these will be visible here soon.

Research Output 2000 2018

2018

Higher expression of MIR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients

Bisagni, A., Pagano, M., Maramotti, S., Zanelli, F., Bonacini, M., Tagliavini, E., Braglia, L., Paci, M., Mozzarelli, A. & Croci, S., Apr 1 2018, In : PLoS One. 13, 4, e0196350.

Research output: Contribution to journalArticle

lung neoplasms
Non-Small Cell Lung Carcinoma
Cells
Epidermal Growth Factor Receptor
Tumors

The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power

PERNO Study Group, Apr 1 2018, In : World Neurosurgery. 112, p. e342-e347

Research output: Contribution to journalArticle

Methyltransferases
DNA Methylation
Glioblastoma
Karnofsky Performance Status
Survival
2017

Italian, multicenter, phase III, randomized study of cisplatin plus etoposide with or without bevacizumab as first-line treatment in extensive-disease small-cell lung cancer: The GOIRC-AIFA FARM6PMFJM trial

Tiseo, M., Boni, L., Ambrosio, F., Camerini, A., Baldini, E., Cinieri, S., Brighenti, M., Zanelli, F., Defraia, E., Chiari, R., Dazzi, C., Tibaldi, C., Turolla, G. M., D'Alessandro, V., Zilembo, N., Trolese, A. R., Grossi, F., Riccardi, F. & Ardizzoni, A., Apr 20 2017, In : Journal of Clinical Oncology. 35, 12, p. 1281-1287 7 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Etoposide
Cisplatin
Survival
Therapeutics

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

Tiseo, M., Boni, L., Ambrosio, F., Camerini, A., Baldini, E., Cinieri, S., Brighenti, M., Zanelli, F., Defraia, E., Chiari, R., Dazzi, C., Tibaldi, C., Turolla, G. M., D'Alessandro, V., Zilembo, N., Trolese, A. R., Grossi, F., Riccardi, F. & Ardizzoni, A., Apr 20 2017, In : Journal of Clinical Oncology. 35, 12, p. 1281-1287 7 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Etoposide
Cisplatin
Survival
Therapeutics
Small Cell Lung Carcinoma
Etoposide
Cisplatin
Survival
Therapeutics

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial

Tiseo, M., Boni, L., Ambrosio, F., Camerini, A., Baldini, E., Cinieri, S., Brighenti, M., Zanelli, F., Defraia, E., Chiari, R., Dazzi, C., Tibaldi, C., Turolla, G. M., D’Alessandro, V., Zilembo, N., Trolese, A. R., Grossi, F., Riccardi, F. & Ardizzoni, A., Jan 30 2017, In : Journal of Clinical Oncology. 35, 12, p. 1281-1287 7 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Etoposide
Cisplatin
Survival
Therapeutics
2015

Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: Treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial

Tiseo, M., Boni, L., Ambrosio, F., Camerini, A., Vitale, M. G., Baldini, E., Cinieri, S., Zanelli, F., Defraia, E., Passalacqua, R., Crino, L., Dazzi, C., Tibaldi, C., Turolla, G. M., D'Alessandro, V., Zilembo, N., Riccardi, F. & Ardizzoni, A., Jan 1 2015, In : Clinical Lung Cancer. 16, 1, p. 67-70 4 p.

Research output: Contribution to journalArticle

Antineoplastic Protocols
Small Cell Lung Carcinoma
Etoposide
Cisplatin
Clinical Trials Data Monitoring Committees

Pei regimen: A therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive cases

Boni, C., Pagano, M., Baldi, L., Gnoni, R., Braglia, L., Savoldi, L. & Zanelli, F., Apr 24 2015, In : Journal of Translational Medicine. 13, 1, 130.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Polyetherimides
Cells
Etoposide
Cisplatin
Cushing Syndrome
Carcinoid Tumor
Lung
Neuroendocrine Tumors
Ectopic Hormones

Surgical Strategy for Malignant Pleural Mesothelioma: Where Are We Going and What Are We Missing?

Lococo, F., Paci, M., Ricchetti, T., Rapicetta, C., Carbonelli, C., Ciammella, P., Zanelli, F., Filice, A., Sgarbi, G. & Cesario, A., Aug 1 2015, In : Annals of Thoracic Surgery. 100, 2, p. 769-770 2 p.

Research output: Contribution to journalArticle

2014

Is there a role for hormonal therapy in neuroendocrine carcinoma of the breast? A paradigmatic case report

Pagano, M., Asensio, S. N. M., Zanelli, F., Lococo, F., Cavazza, A., Damiani, S., Rapicetta, C., Gnoni, R. & Boni, C., 2014, In : Clinical Breast Cancer. 14, 5, p. e99-e101

Research output: Contribution to journalArticle

2013

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

Tiseo, M., Bordi, P., Bortesi, B., Boni, L., Boni, C., Baldini, E., Grossi, F., Recchia, F., Zanelli, F., Fontanini, G., Naldi, N., Campanini, N., Azzoni, C., Bordi, C. & Ardizzoni, A., Apr 30 2013, In : British Journal of Cancer. 108, 8, p. 1695-1703 9 p.

Research output: Contribution to journalArticle

BRCA1 Gene
Non-Small Cell Lung Carcinoma
Cisplatin
Genes
Therapeutics
2012

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: A multicenter randomised factorial trial (FAST)

Boni, C., Tiseo, M., Boni, L., Baldini, E., Recchia, F., Barone, C., Grossi, F., Germano, D., Matano, E., Marini, G., Labianca, R., Di Costanzo, F., Bagnulo, A., Pennucci, C., Caroti, C., Mencoboni, M., Zanelli, F., Prochilo, T., Cafferata, M. A. & Ardizzoni, A., Feb 14 2012, In : British Journal of Cancer. 106, 4, p. 658-665 8 p.

Research output: Contribution to journalArticle

gemcitabine
Non-Small Cell Lung Carcinoma
Cisplatin
Ifosfamide
Therapeutics
2006

Non-small-cell lung cancer: Which platinum for gemcitabine?

Boni, C., Zanelli, F., Ambroggi, M. & Bologna, A., May 2006, In : Annals of Oncology. 17, SUPPL. 5

Research output: Contribution to journalArticle

2003

Ifosfamide in non-small cell lung cancer

Boni, C. & Zanelli, F., 2003, In : Oncology. 65, SUPPL. 2, p. 50-54 5 p.

Research output: Contribution to journalArticle

Ifosfamide
Non-Small Cell Lung Carcinoma
Pharmaceutical Preparations
Cytostatic Agents
gemcitabine

Preoperative concomitant radiotherapy and chemotherapy in ultrasound-staged T3 and T4 rectal cancer

Luppi, G., Santantonio, M., Bertolini, F., Fiorica, F., Zanelli, F., Gavioli, M., Balli, M. & Silingardi, V., Mar 2003, In : Tumori. 89, 2, p. 152-156 5 p.

Research output: Contribution to journalArticle

Rectal Neoplasms
Radiotherapy
Drug Therapy
Chemoradiotherapy
Fluorouracil
2002

FOLFOX 2 regimen in heavily pretreated patients with advanced colorectal cancer

Luppi, G., Zanelli, F., Di Stasi, A., Bertolini, F. & Pifferi, M., Jul 2002, In : Tumori. 88, 4, p. 270-272 3 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
oxaliplatin
Safety
Survival
Leucovorin
2000

Cure palliative e assistenza domiciliare al paziente oncologico

Translated title of the contribution: Palliative care and home support for oncologic patientsPiccinini, L., Depenni, R., Zoboli, A., Zanelli, F., Clo, V. & Arigliano, V., 2000, In : Tumori. 86, 3 SUPPL.

Research output: Contribution to journalArticle